Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

News in brief

Evonik buys pharma & fine chem separations specialist MET

04-Mar-2010

Related topics: Processing & QC

Evonik has bought Membrane Extraction Technology (MET), strengthening its pharma and fine chemical separation capabilities and continuing a busy week of acquisitions for the company.

Earlier this week Evonik acquired Amperkat catalysts from HC Starck and this has been followed by the purchase of MET. Evonik stated the MET acquisition taps a promising growth market for its high-performance polymer business.

There will be a fast growing demand for energy & environmental friendly solutions like membrane based technologies”, explained Joachim Leluschko, head of Evonik’s high performance polymers business line.

He added: “MET’s proprietary technology complements Evonik’s process competence and global market presence very well and fastens our access to this attractive market.”

Follow us on